Sign In
Buy NURO
$4.58
+0 (+0%)
At Close: Jul 30, 2025
Local med device firm slashes CEO pay to $1 amid financial woes
11:32am, Monday, 06'th Jan 2020
Once considered one of the state’s fastest-growing public companies, a Woburn medical device company has made a series of substantial cuts over the last year in the hopes of bringing the company out
NuVasive (NUVA) Hits 52-Week High, Can the Run Continue?
02:25pm, Friday, 06'th Dec 2019
NuVasive (NUVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
NeuroMetrix Announces One-for-Ten Reverse Split
04:50pm, Monday, 18'th Nov 2019
NeuroMetrix, Inc. (NURO) today announced the effectiveness of a one-for-ten reverse split of its common stock. The shares underlying the Company's outstanding options and warrants will also be adjust
NeuroMetrix Reports 1-For-10 Reverse Stock Split, Effective Nov. 18, 2019
12:00am, Monday, 18'th Nov 2019NeuroMetrix (NASDAQ:NURO) Will Have To Spend Its Cash Wisely
02:07pm, Wednesday, 13'th Nov 2019
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance
12:00am, Friday, 01'st Nov 20192020 Volvo S90 review: Subtly outstanding
09:00am, Monday, 28'th Oct 2019
An ideal luxury sedan for customers who dare to be different, the Volvo S90 is a breath of fresh air in a segment dominated by German offerings.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 17) Applied Therapeutics Inc (NASDAQ: APLT ) Arrowhead
